158 related articles for article (PubMed ID: 31915990)
101. CFTR Correctors and Antioxidants Partially Normalize Lipid Imbalance but not Abnormal Basal Inflammatory Cytokine Profile in CF Bronchial Epithelial Cells.
Veltman M; De Sanctis JB; Stolarczyk M; Klymiuk N; Bähr A; Brouwer RW; Oole E; Shah J; Ozdian T; Liao J; Martini C; Radzioch D; Hanrahan JW; Scholte BJ
Front Physiol; 2021; 12():619442. PubMed ID: 33613309
[TBL] [Abstract][Full Text] [Related]
102. Druggable Sphingolipid Pathways: Experimental Models and Clinical Opportunities.
Blaho VA
Adv Exp Med Biol; 2020; 1274():101-135. PubMed ID: 32894509
[TBL] [Abstract][Full Text] [Related]
103. Modeling responses to respiratory house dust mite exposure.
Cates EC; Fattouh R; Johnson JR; Llop-Guevara A; Jordana M
Contrib Microbiol; 2007; 14():42-67. PubMed ID: 17684332
[TBL] [Abstract][Full Text] [Related]
104. Efficacy of Optimized Treatment Protocol Using LAU-7b Formulation against Ovalbumin (OVA) and House Dust Mite (HDM) -Induced Allergic Asthma in Atopic Hyperresponsive A/J Mice.
Youssef M; De Sanctis JB; Kanagaratham C; Tao S; Ahmed E; Radzioch D
Pharm Res; 2020 Jan; 37(2):31. PubMed ID: 31915990
[TBL] [Abstract][Full Text] [Related]
105. Treatment of Allergic Asthma with Fenretinide Formulation (LAU-7b) Downregulates ORMDL Sphingolipid Biosynthesis Regulator 3 (
Youssef M; De Sanctis JB; Shah J; Dumut DC; Hajduch M; Naumova AK; Radzioch D
J Pharmacol Exp Ther; 2020 Jun; 373(3):476-487. PubMed ID: 32273303
[TBL] [Abstract][Full Text] [Related]
106. The interleukin-33 receptor ST2 is important for the development of peripheral airway hyperresponsiveness and inflammation in a house dust mite mouse model of asthma.
Zoltowska AM; Lei Y; Fuchs B; Rask C; Adner M; Nilsson GP
Clin Exp Allergy; 2016 Mar; 46(3):479-90. PubMed ID: 26609909
[TBL] [Abstract][Full Text] [Related]
107. A critical role for C5L2 in the pathogenesis of experimental allergic asthma.
Zhang X; Schmudde I; Laumonnier Y; Pandey MK; Clark JR; König P; Gerard NP; Gerard C; Wills-Karp M; Köhl J
J Immunol; 2010 Dec; 185(11):6741-52. PubMed ID: 20974988
[TBL] [Abstract][Full Text] [Related]
108. House dust mite allergic airway inflammation facilitates neosensitization to inhaled allergen in mice.
van Rijt LS; Logiantara A; Utsch L; Canbaz D; Boon L; van Ree R
Allergy; 2012 Nov; 67(11):1383-91. PubMed ID: 22994367
[TBL] [Abstract][Full Text] [Related]
109. Fenretinide prevents inflammation and airway hyperresponsiveness in a mouse model of allergic asthma.
Kanagaratham C; Kalivodová A; Najdekr L; Friedecký D; Adam T; Hajduch M; De Sanctis JB; Radzioch D
Am J Respir Cell Mol Biol; 2014 Dec; 51(6):783-92. PubMed ID: 24885263
[TBL] [Abstract][Full Text] [Related]
110. Oxidative stress and abnormal bioactive lipids in early cystic fibrosis lung disease.
Scholte BJ; Horati H; Veltman M; Vreeken RJ; Garratt LW; Tiddens HAWM; Janssens HM; Stick SM;
J Cyst Fibros; 2019 Nov; 18(6):781-789. PubMed ID: 31031161
[TBL] [Abstract][Full Text] [Related]
111. Ceramide Imbalance and Impaired TLR4-Mediated Autophagy in BMDM of an ORMDL3-Overexpressing Mouse Model.
Kiefer K; Casas J; García-López R; Vicente R
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30897694
[TBL] [Abstract][Full Text] [Related]
112. Biochemistry of very-long-chain and long-chain ceramides in cystic fibrosis and other diseases: The importance of side chain.
Garić D; De Sanctis JB; Shah J; Dumut DC; Radzioch D
Prog Lipid Res; 2019 Apr; 74():130-144. PubMed ID: 30876862
[TBL] [Abstract][Full Text] [Related]
113. Depletion of BAFF cytokine exacerbates infection in Pseudomonas aeruginosa infected mice.
Garić D; Tao S; Ahmed E; Youssef M; Kanagaratham C; Shah J; Mazer B; Radzioch D
J Cyst Fibros; 2019 May; 18(3):349-356. PubMed ID: 30527891
[TBL] [Abstract][Full Text] [Related]
114. The ORMDL3 Asthma Gene Regulates ICAM1 and Has Multiple Effects on Cellular Inflammation.
Zhang Y; Willis-Owen SAG; Spiegel S; Lloyd CM; Moffatt MF; Cookson WOCM
Am J Respir Crit Care Med; 2019 Feb; 199(4):478-488. PubMed ID: 30339462
[TBL] [Abstract][Full Text] [Related]
115. Repurposing drugs as inhaled therapies in asthma.
Anderson SD
Adv Drug Deliv Rev; 2018 Aug; 133():19-33. PubMed ID: 29906501
[TBL] [Abstract][Full Text] [Related]
116.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
117.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
118.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
119.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
120.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
